0001209191-22-027164.txt : 20220504
0001209191-22-027164.hdr.sgml : 20220504
20220504171743
ACCESSION NUMBER: 0001209191-22-027164
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220503
FILED AS OF DATE: 20220504
DATE AS OF CHANGE: 20220504
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Metcalfe David A
CENTRAL INDEX KEY: 0001664295
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12537
FILM NUMBER: 22892646
MAIL ADDRESS:
STREET 1: 3525 PIEDMONT RD., NE
STREET 2: BUILDING 6, SUITE 700
CITY: ATLANTA
STATE: GA
ZIP: 30305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEXTGEN HEALTHCARE, INC.
CENTRAL INDEX KEY: 0000708818
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
IRS NUMBER: 952888568
STATE OF INCORPORATION: CA
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 3525 PIEDMONT RD., NE
STREET 2: BUILDING 6, SUITE 700
CITY: ATLANTA
STATE: GA
ZIP: 30305
BUSINESS PHONE: 404-467-1500
MAIL ADDRESS:
STREET 1: 3525 PIEDMONT RD., NE
STREET 2: BUILDING 6, SUITE 700
CITY: ATLANTA
STATE: GA
ZIP: 30305
FORMER COMPANY:
FORMER CONFORMED NAME: QUALITY SYSTEMS, INC
DATE OF NAME CHANGE: 20180823
FORMER COMPANY:
FORMER CONFORMED NAME: NEXTGEN HEALTHCARE, INC
DATE OF NAME CHANGE: 20180823
FORMER COMPANY:
FORMER CONFORMED NAME: QUALITY SYSTEMS, INC
DATE OF NAME CHANGE: 20100804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-03
0
0000708818
NEXTGEN HEALTHCARE, INC.
NXGN
0001664295
Metcalfe David A
3525 PIEDMONT RD., NE
BUILDING 6, SUITE 700
ATLANTA
GA
30305
0
1
0
0
Chief Technology Officer
Common Stock
2022-05-03
4
M
0
16162
14.20
A
171175
D
Common Stock
2022-05-03
4
M
0
17676
14.07
A
188851
D
Common Stock
2022-05-03
4
S
0
33838
20.0019
D
155013
D
Stock Option (right to buy)
14.20
2022-05-03
4
M
0
16162
0.00
D
2024-02-01
Common Stock
16162
150000
D
Stock Option (right to buy)
14.07
2022-05-03
4
M
0
17676
0.00
D
2025-10-31
Common Stock
17676
122324
D
Pursuant to a 10b5-1(c) plan adopted by the reporting person on March 15, 2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to
$20.085. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholders
upon request.
Original grant of 200,000 options granted on 2/1/2016 vested in four equal, annual installments beginning 2/1/2017.
Original grant of 140,000 options granted on 10/31/2017 vested in four equal, annual installments beginning 10/31/2018.
/s/ Jeffrey D. Linton, Attorney-in-Fact for David A.Metcalfe
2022-05-04